Treatment of Dystonia

Selecting the appropriate treatment for dystonia begins with proper classification of disease based on age, distribution, and underlying etiology. The therapies available for dystonia include oral medications, botulinum toxin, and surgical procedures. Oral medications are generally reserved for generalized and segmental dystonia. Botulinum toxin revolutionized the treatment of focal dystonia when it was introduced for therapeutic purposes in the 1980s. Surgical procedures are available for medication-refractory dystonia, markedly affecting an individual’s quality of life.

[1]  B. Wabbels,et al.  Long-term follow-up of patients with frontalis sling operation in the treatment of essential blepharospasm unresponsive to botulinum toxin therapy , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  C. Marsden,et al.  Torsion dystonia , 1986, Neurology.

[3]  A. Destée,et al.  Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. , 2005, The New England journal of medicine.

[4]  J. Dostrovsky,et al.  Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia , 2007, Neurology.

[5]  E. Foncke,et al.  Suicide after deep brain stimulation of the internal globus pallidus for dystonia , 2006, Neurology.

[6]  D. Gruber,et al.  Long-term effects of pallidal deep brain stimulation in tardive dystonia , 2009, Neurology.

[7]  B. Jespersen,et al.  A randomized double-blind crossover trial comparing subthalamic and pallidal deep brain stimulation for dystonia. , 2013, Journal of neurosurgery.

[8]  D. Calne,et al.  Botulinum toxin in the treatment of writer's cramp , 1993, Neurology.

[9]  M. Aminoff,et al.  Botulinum toxin therapy for limb dystonias , 1992, Neurology.

[10]  A. Priori,et al.  Novel nonpharmacologic perspectives for the treatment of task-specific focal hand dystonia. , 2009, Journal of hand therapy : official journal of the American Society of Hand Therapists.

[11]  W. Ondo,et al.  Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. , 2008, Parkinsonism & related disorders.

[12]  S. Matayoshi,et al.  Browlifting as an alternative procedure for apraxia of eyelid opening. , 2009, Ophthalmic plastic and reconstructive surgery.

[13]  J. Jankovic,et al.  Intrathecal baclofen for intractable axial dystonia , 1991, Neurology.

[14]  S. Bressman,et al.  Milestones in dystonia , 2011, Movement disorders : official journal of the Movement Disorder Society.

[15]  S. Fahn,et al.  Outcome of selective ramisectomy for botulinum toxin resistant torticollis , 1998, Journal of neurology, neurosurgery, and psychiatry.

[16]  J. Matsumoto,et al.  Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic. , 2003, Journal of neurosurgery.

[17]  M. Brin,et al.  Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis , 1990, Neurology.

[18]  D M Simpson,et al.  Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) , 2008, Neurology.

[19]  P. Brennan,et al.  Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain , 2008, British journal of neurosurgery.

[20]  C D Marsden,et al.  Dopa‐responsive dystonia , 1991, Neurology.

[21]  G. Deuschl,et al.  Pallidal deep-brain stimulation in primary generalized or segmental dystonia. , 2006, The New England journal of medicine.

[22]  Y. Guo,et al.  Oxcarbazepine Versus Carbamazepine in the Treatment of Paroxysmal Kinesigenic Dyskinesia , 2012, The International journal of neuroscience.

[23]  S. Fahn,et al.  Baclofen in the treatment of idiopathic dystonia in children , 1992, Movement disorders : official journal of the Movement Disorder Society.

[24]  J K Krauss,et al.  Battery lifetime in pallidal deep brain stimulation for dystonia , 2011, European journal of neurology.

[25]  P. Starr,et al.  Subthalamic nucleus deep brain stimulation in primary cervical dystonia , 2011, Neurology.

[26]  T. Shimohata,et al.  Cervical dystonia associated with spinocerebellar ataxia type 2 successfully treated with levodopa: A case report , 2009, Movement disorders : official journal of the Movement Disorder Society.

[27]  P. Starr,et al.  Shorter disease duration correlates with improved long-term deep brain stimulation outcomes in young-onset DYT1 dystonia. , 2012, Neurosurgery.

[28]  Keyoumars Ashkan,et al.  Accuracy of stimulating electrode placement in paediatric pallidal deep brain stimulation for primary and secondary dystonia , 2013, Acta Neurochirurgica.

[29]  G. K. Røste,et al.  Good long‐term efficacy of pallidal stimulation in cervical dystonia: a prospective, observer‐blinded study , 2012, European journal of neurology.

[30]  E. Granieri,et al.  Five-Year Follow-Up of 10 Patients Treated with Globus Pallidus Internus Deep Brain Stimulation for Segmental or Multisegmental Dystonia , 2012, Stereotactic and Functional Neurosurgery.

[31]  J. Jankovic,et al.  Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia , 2013, Toxins.

[32]  J. Volkmann,et al.  Long‐term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase‐associated neurodegeneration , 2006, Movement disorders : official journal of the Movement Disorder Society.

[33]  Rechargeable vs. Nonrechargeable Internal Pulse Generators in the Management of Dystonia , 2013, Neuromodulation : journal of the International Neuromodulation Society.

[34]  Manoel Jacobsen Teixeira,et al.  Bilateral subthalamic nucleus stimulation for generalized dystonia after bilateral pallidotomy , 2012, Movement disorders : official journal of the Movement Disorder Society.

[35]  S. Golaszewski,et al.  Successful treatment of musician's dystonia using repetitive transcranial magnetic stimulation , 2013, Clinical Neurology and Neurosurgery.

[36]  M. Hennerici,et al.  Micrographia induced by pallidal DBS for segmental dystonia: a subtle sign of hypokinesia? , 2011, Journal of Neural Transmission.

[37]  K. Asanuma,et al.  Efficacy of Zolpidem for Dystonia: A Study Among Different Subtypes , 2012, Front. Neur..

[38]  L. Hollier,et al.  Effect of dietary zinc and phytase supplementation on botulinum toxin treatments. , 2012, Journal of drugs in dermatology : JDD.

[39]  W. Ondo,et al.  Intrathecal baclofen for dystonia , 2001, Movement disorders : official journal of the Movement Disorder Society.

[40]  B. Rocque,et al.  Intraventricular vs Intrathecal Baclofen for Secondary Dystonia: A Comparison of Complications , 2012, Neurosurgery.

[41]  H. Fernandez,et al.  The Promise of Deep Brain Stimulation in X-Linked Dystonia Parkinsonism , 2011, The International journal of neuroscience.

[42]  M. Jahanshahi,et al.  Neuropsychological, neuropsychiatric, and quality of life issues in DBS for dystonia , 2011, Movement disorders : official journal of the Movement Disorder Society.

[43]  M. Hallett,et al.  An open trial of clozapine for dystonia , 1999, Movement disorders : official journal of the Movement Disorder Society.

[44]  M. Tijssen,et al.  Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value , 2012, Journal of Neurology.

[45]  J. Jankovic,et al.  Autonomic function after botulinum toxin type A or B: A double-blind, randomized trial , 2005, Neurology.

[46]  P. Roggenkämper,et al.  Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.

[47]  P. Krack,et al.  Long‐Term management of DBS in dystonia: Response to stimulation, adverse events, battery changes, and special considerations , 2011, Movement disorders : official journal of the Movement Disorder Society.

[48]  R. Bakay,et al.  Stimulation-induced parkinsonism after posteroventral deep brain stimulation of the globus pallidus internus for craniocervical dystonia. , 2009, Journal of neurosurgery.

[49]  A. L. Albright,et al.  Intraventricular baclofen for dystonia: techniques and outcomes. Clinical article. , 2009, Journal of neurosurgery. Pediatrics.

[50]  Naoki Nakano,et al.  Neuromodulation using intrathecal baclofen therapy for spasticity and dystonia. , 2012, Neurologia medico-chirurgica.

[51]  R. D. de Haan,et al.  Botulinum toxin for writer’s cramp: a randomised, placebo-controlled trial and 1-year follow-up , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[52]  D. Jokisch,et al.  Pallidal deep brain stimulation relieves camptocormia in primary dystonia , 2013, Journal of Neurology.

[53]  N. Pavese.  Dystonia: hopes for a better diagnosis and a treatment with long-lasting effect. , 2013, Brain : a journal of neurology.

[54]  W. Jost,et al.  Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm , 2006, Journal of Neural Transmission.

[55]  Sanjeev Arora,et al.  Multiple sessions of low-frequency repetitive transcranial magnetic stimulation in focal hand dystonia: clinical and physiological effects. , 2013, Restorative neurology and neuroscience.

[56]  J. Ostrem,et al.  Use of Pallidal Deep Brain Stimulation in Postinfarct Hemidystonia , 2013, Stereotactic and Functional Neurosurgery.

[57]  K. Bhatia,et al.  The genetics of dystonia: new twists in an old tale , 2013, Brain : a journal of neurology.

[58]  M. Vagefi,et al.  Upper eyelid myectomy in blepharospasm with associated apraxia of lid opening. , 2008, American journal of ophthalmology.

[59]  K. Dujardin,et al.  Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study , 2007, The Lancet Neurology.

[60]  F. Eichler,et al.  Sepiapterin reductase deficiency: A Treatable Mimic of Cerebral Palsy , 2012, Annals of neurology.

[61]  R. Leadbetter,et al.  Treatment of severe axial tardive dystonia with clozapine: Case report and hypothesis , 1994, Movement disorders : official journal of the Movement Disorder Society.

[62]  Günther Deuschl,et al.  Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial , 2012, The Lancet Neurology.

[63]  A. Berardelli,et al.  Efficacy and Safety of Long-term Botulinum Toxin Treatment in Craniocervical Dystonia: A Systematic Review , 2012, Neurotoxicity Research.

[64]  E. Růžička,et al.  A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia , 2005, Neurology.

[65]  G. Deuschl,et al.  What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport® , 1998, Journal of neurology, neurosurgery, and psychiatry.

[66]  J. Kuratsu,et al.  Long Disease Duration Interferes With Therapeutic Effect of Globus Pallidus Internus Pallidal Stimulation in Primary Cervical Dystonia , 2013, Neuromodulation : journal of the International Neuromodulation Society.

[67]  P. Pearl,et al.  The Pediatric Neurotransmitter Disorders , 2007, Journal of child neurology.

[68]  J. Jankovic,et al.  Diffusion, spread, and migration of botulinum toxin , 2013, Movement disorders : official journal of the Movement Disorder Society.

[69]  H. Hjaltason,et al.  A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox®in the treatment of cervical dystonia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[70]  M. Hallett,et al.  Sensory aspects of movement disorders , 2014, The Lancet Neurology.

[71]  Sang-Kyou Lee,et al.  Alleviation of abnormal synaptic neurotransmitter release by cell-permeable form of the truncated SNAP-25 upon transcutaneous delivery , 2013, Neuroscience Letters.

[72]  A. L. Albright,et al.  Intrathecal baclofen for generalized dystonia. , 2001, Developmental medicine and child neurology.

[73]  G. Deuschl,et al.  Long‐term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation , 2011, Movement disorders : official journal of the Movement Disorder Society.

[74]  J. Jankovic,et al.  Pallidotomy for generalized dystonia , 1998, Movement disorders : official journal of the Movement Disorder Society.

[75]  M. Hariz,et al.  Bilateral deep brain stimulation for cervical dystonia in patients with previous peripheral surgery , 2012, Movement disorders : official journal of the Movement Disorder Society.

[76]  J. Jankovic,et al.  Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders , 2011, Expert review of neurotherapeutics.

[77]  S. Krahl,et al.  Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. , 2007, Acta neurochirurgica. Supplement.

[78]  M. Okun,et al.  Should We Consider Vim Thalamic Deep Brain Stimulation for Select Cases of Severe Refractory Dystonic Tremor , 2010, Stereotactic and Functional Neurosurgery.

[79]  K. Dujardin,et al.  Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study , 2009, The Lancet Neurology.

[80]  K. Ashkan,et al.  Battery life following pallidal deep brain stimulation (DBS) in children and young people with severe primary and secondary dystonia , 2012, Child's Nervous System.

[81]  E. Pappert,et al.  Botulinum toxin type B vs. type A in toxin‐naïve patients with cervical dystonia: Randomized, double‐blind, noninferiority trial , 2008, Movement disorders : official journal of the Movement Disorder Society.

[82]  D. Kondziolka,et al.  Bilateral subthalamic nucleus deep brain stimulation for dopa-responsive dystonia in a 6-year-old child. , 2011, Journal of neurosurgery. Pediatrics.

[83]  T. Pin,et al.  Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review , 2011, Developmental medicine and child neurology.

[84]  J. Jankovic,et al.  Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled study , 2005, Movement disorders : official journal of the Movement Disorder Society.

[85]  D. Calne,et al.  The long-term response to levodopa in dopa-responsive dystonia. , 2001, Parkinsonism & related disorders.

[86]  L. Avanzino,et al.  KinesioTaping Reduces Pain and Modulates Sensory Function in Patients With Focal Dystonia , 2013, Neurorehabilitation and neural repair.

[87]  K P Bhatia,et al.  Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[88]  M. Hallett,et al.  Phenomenology and classification of dystonia: A consensus update , 2013, Movement disorders : official journal of the Movement Disorder Society.

[89]  J D Speelman,et al.  Deep brain stimulation for dystonia: patient selection and outcomes , 2010, European journal of neurology.

[90]  J. Jankovic,et al.  Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial , 2011, Movement disorders : official journal of the Movement Disorder Society.

[91]  P. Ktonas,et al.  Transcranial alternating current stimulation reduces symptoms in intractable idiopathic cervical dystonia: A case study , 2013, Neuroscience Letters.

[92]  B. Wabbels,et al.  Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm , 2011, Journal of Neural Transmission.

[93]  M. Jahanshahi,et al.  Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. , 2001, Brain : a journal of neurology.

[94]  E. Chang,et al.  Long-Term Benefit Sustained after Bilateral Pallidal Deep Brain Stimulation in Patients with Refractory Tardive Dystonia , 2010, Stereotactic and Functional Neurosurgery.

[96]  A. Cohen-Gadol,et al.  Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations. , 2012, Journal of neurosurgery. Pediatrics.

[97]  M. Hariz,et al.  Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[98]  M. Eliasziw,et al.  The Canadian multicentre study of deep brain stimulation for cervical dystonia. , 2007, Brain : a journal of neurology.

[99]  E. Barbosa,et al.  Physical therapy program for cervical dystonia: a study of 20 cases. , 2012, Functional neurology.

[100]  D. Dressler.  Five‐year experience with incobotulinumtoxinA (Xeomin®): the first botulinum toxin drug free of complexing proteins , 2012, European journal of neurology.

[101]  J. Jankovic,et al.  Zolpidem improves tardive dyskinesia and akathisia , 2013, Movement disorders : official journal of the Movement Disorder Society.

[102]  J. Jankovic,et al.  Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia , 2003, Neurology.

[103]  J. Jankovic,et al.  Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. , 2010, Parkinsonism & related disorders.

[104]  V. P. Misra,et al.  Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study , 2012, BMJ Open.

[105]  G. Nappi,et al.  Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia , 2006, Movement disorders : official journal of the Movement Disorder Society.

[106]  A. Aronson,et al.  Double‐blind controlled study of botulinum toxin in adductor spasmodic dysphonia , 1991, The Laryngoscope.

[107]  J. Jankovic,et al.  Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia , 2011, Journal of the Neurological Sciences.

[108]  J. Jankovic,et al.  Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia , 1997, Neurology.

[109]  Jin-Woo Chung,et al.  Effect of Botulinum Toxin Injection on Nocturnal Bruxism: A Randomized Controlled Trial , 2010, American journal of physical medicine & rehabilitation.

[110]  V. Braun,et al.  Selective peripheral denervation for spasmodic torticollis: 13-year experience with 155 patients. , 2002, Journal of neurosurgery.

[111]  A. Lozano,et al.  Surgical treatment for secondary dystonia , 2012, Movement disorders : official journal of the Movement Disorder Society.

[112]  J. Koelman,et al.  Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review. , 2012, Parkinsonism & related disorders.

[113]  M. Satoh,et al.  Three Cases of Focal Embouchure Dystonia: Classifications and Successful Therapy Using a Dental Splint , 2011, European Neurology.

[114]  S. Frucht,et al.  A pilot tolerability and efficacy trial of sodium oxybate in ethanol‐responsive movement disorders , 2005, Movement disorders : official journal of the Movement Disorder Society.

[115]  R. Alterman,et al.  Deep brain stimulation in DYT1 dystonia: a 10-year experience. , 2013, Neurosurgery.

[116]  J. Jankovic,et al.  Zolpidem Improves Tardive Dyskinesia with and without Akathisia (P07.205) , 2013 .

[117]  J. Jankovic,et al.  Tetrabenazine for treatment of chorea associated with Huntington's disease and other potential indications , 2013 .

[118]  J. Burgunder,et al.  Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease duration , 2011, Journal of Neurology.

[119]  J. Krauss,et al.  Combined pallidal and subthalamic nucleus stimulation in sporadic dystonia-parkinsonism. , 2012, Journal of neurosurgery.

[120]  R. Bhidayasiri.  Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses. , 2011, Parkinsonism & related disorders.

[121]  J Jankovic,et al.  Botulinum A toxin for cranial‐cervical dystonia , 1987, Neurology.

[122]  A. Lozano,et al.  Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years. , 2013, Brain : a journal of neurology.

[123]  J. Jankovic.  Medical treatment of dystonia , 2013, Movement disorders : official journal of the Movement Disorder Society.

[124]  Dianyou Li,et al.  Subthalamus deep brain stimulation for primary dystonia patients: A long‐term follow‐up study , 2013, Movement disorders : official journal of the Movement Disorder Society.

[125]  M. Hallett,et al.  Double‐Blind trial of botulinum toxin for treatment of focal hand dystonia , 1995, Movement disorders : official journal of the Movement Disorder Society.

[126]  D. Hodge,et al.  Follow-up of patients with essential blepharospasm who underwent eyelid protractor myectomy at the Mayo Clinic from 1980 through 1995. , 1999, Ophthalmic plastic and reconstructive surgery.

[127]  R. Alterman,et al.  Pallidal Deep Brain Stimulation for Primary Dystonia in Children , 2011, Neurosurgery.

[128]  R. Gross.  What happened to posteroventral pallidotomy for Parkinson’s disease and dystonia? , 2008, Neurotherapeutics.

[129]  S. Chouinard,et al.  A Case of Secondary Dystonia Responding to Levodopa , 2010, Journal of child neurology.

[130]  J. Jankovic,et al.  Long‐term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders , 2007, Movement disorders : official journal of the Movement Disorder Society.

[131]  J. Saint-Cyr,et al.  Cognitive processes in idiopathic dystonia treated with high-dose anticholinergic therapy: implications for treatment strategies. , 1991, Clinical neuropharmacology.

[132]  L. Bailey,et al.  Dystonia due to cerebral palsy responds to deep brain stimulation of the globus pallidus internus , 2011, Movement disorders : official journal of the Movement Disorder Society.

[133]  J. Jankovic,et al.  Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. , 1999, Neurology.

[134]  M. Hallett,et al.  Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. , 2013, Toxicon : official journal of the International Society on Toxinology.

[135]  M. Brin,et al.  Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. , 1999, Neurology.

[136]  J. Krauss,et al.  GPi-DBS may induce a hypokinetic gait disorder with freezing of gait in patients with dystonia , 2011, Neurology.

[137]  S. Chung,et al.  Comparison of Treatment Results between Selective Peripheral Denervation and Deep Brain Stimulation in Patients with Cervical Dystonia , 2010, Stereotactic and Functional Neurosurgery.

[138]  S. Hemm,et al.  Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. , 2004, Journal of neurosurgery.

[139]  K. Ashkan,et al.  Rechargeable Deep Brain Stimulators in the Management of Paediatric Dystonia: Well Tolerated with a Low Complication Rate , 2012, Stereotactic and Functional Neurosurgery.

[140]  M. Vidailhet,et al.  Myoclonus‐dystonia: An update , 2009, Movement disorders : official journal of the Movement Disorder Society.

[141]  P. Starr,et al.  Predictive factors of outcome in primary cervical dystonia following pallidal deep brain stimulation , 2013, Movement disorders : official journal of the Movement Disorder Society.